Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Jayson D.A. Dallas, insider at Arena Pharmaceuticals
Jayson D.A. Dallas Insider Alerts

Get notified the next time Jayson D.A. Dallas buys or sells Arena Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

Jayson D.A. Dallas Insider Information

Dr. Jayson D.A. Dallas M.D. serves as Independent Director of the Company. Dr. Dallas has served on our Board of Directors since February 2017. He has served as President and Chief Executive Officer of Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, since June 2018. Prior to joining Aimmune, he served as the first Chief Commercial Officer and Executive Vice President of Ultragenyx Pharmaceutical, Inc., a publicly held biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, since August 2015. Prior to Ultragenyx, Dr. Dallas served as General Manager of Roche, a healthcare company, in the United Kingdom from January 2013 to July 2015. Before joining Roche, he held two different positions at Genentech, a pharmaceutical company, as Head of Global Oncology Launch Excellence and Biosimilar Strategy and Head of Global Product Strategy for Immunology and Ophthalmology, from May 2010 to December 2012 in South San Francisco. Earlier in his career, Dr. Dallas worked at Novartis and Pfizer / Pharmacia in the United States and previously at Roche in Switzerland. Dr. Dallas holds an M.D. from the University of the Witwatersrand, Johannesburg, South Africa and an M.B.A. from Ashridge Business School in the United Kingdom.

What is Jayson D.A. Dallas' net worth?

The estimated net worth of Jayson D.A. Dallas is at least $414,981.25 as of June 15th, 2021. Dr. Dallas owns 8,375 shares of Arena Pharmaceuticals stock worth more than $414,981 as of December 5th. This net worth approximation does not reflect any other investments that Dr. Dallas may own. Learn More.

How do I contact Jayson D.A. Dallas?

The corporate mailing address for Dr. Dallas and other Arena Pharmaceuticals executives is 6154 Nancy Ridge Drive, San Diego CA, 92121. Arena Pharmaceuticals can also be reached via phone at (858) 453-7200 and via email at [email protected]

Has Jayson D.A. Dallas been buying or selling shares of Arena Pharmaceuticals?

Jayson D.A. Dallas has not been actively trading shares of Arena Pharmaceuticals within the last three months. Most recently, Jayson Donald Alexander Dallas sold 1,223 shares of the business's stock in a transaction on Tuesday, June 15th. The shares were sold at an average price of $66.36, for a transaction totalling $81,158.28. Following the completion of the sale, the director now directly owns 8,375 shares of the company's stock, valued at $555,765.

Who are Arena Pharmaceuticals' active insiders?

Arena Pharmaceuticals' insider roster includes Jayson Dallas (Director), Robert Lisicki (EVP), Robert Lisicki (EVP), and Amit Munshi (CEO).

Are insiders buying or selling shares of Arena Pharmaceuticals?

During the last year, Arena Pharmaceuticals insiders bought shares 4 times. They purchased a total of 3,005 shares worth more than $151,841.25. During the last year, insiders at the biopharmaceutical company sold shares 9 times. They sold a total of 161,468 shares worth more than $12,426,897.02. The most recent insider tranaction occured on August, 16th when CEO Amit Munshi bought 1,000 shares worth more than $48,190.00. Insiders at Arena Pharmaceuticals own 3.1 % of the company.

Information on this page was last updated on 8/16/2021.

Jayson D.A. Dallas Insider Trading History at Arena Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2021Sell1,223$66.36$81,158.288,375View SEC Filing Icon  
1/19/2021Sell1,327$80.50$106,823.505,308View SEC Filing Icon  
12/8/2020Buy5$66.25$331.256,630View SEC Filing Icon  
6/14/2019Sell1,525$55.90$85,247.505,704View SEC Filing Icon  
See Full Table

Jayson D.A. Dallas Buying and Selling Activity at Arena Pharmaceuticals

This chart shows Jayson Donald Alexander Dallas's buying and selling at Arena Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arena Pharmaceuticals Company Overview

Arena Pharmaceuticals logo
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.
Read More

Today's Range

Now: $49.55
Low: $48.43
High: $53.91

50 Day Range

MA: $59.39
Low: $49.55
High: $63.74

2 Week Range

Now: $49.55
Low: $45.50
High: $85.00

Volume

779,533 shs

Average Volume

414,183 shs

Market Capitalization

$3.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!